Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.22 USD | +4.72% | +9.36% | -1.33% |
May. 10 | TherapeuticsMD, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 29 | TherapeuticsMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2022 | 69.96M | Sales 2023 | 1.3M | Capitalization | 25.77M |
---|---|---|---|---|---|
Net income 2022 | 112M | Net income 2023 | -10M | EV / Sales 2022 | 0.34 x |
Net cash position 2022 | 29.31M | Net Debt 2023 | 3.68M | EV / Sales 2023 | 22.6 x |
P/E ratio 2022 |
0.47
x | P/E ratio 2023 |
-2.28
x | Employees | 1 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.06% |
1 day | +4.72% | ||
1 week | +9.36% | ||
Current month | +18.09% | ||
1 month | +17.46% | ||
3 months | -1.77% | ||
6 months | -2.20% | ||
Current year | -1.33% |
Managers | Title | Age | Since |
---|---|---|---|
Marlan Walker
CEO | Chief Executive Officer | 50 | 13-05-31 |
Joseph Ziegler
DFI | Director of Finance/CFO | - | 23-08-16 |
Corporate Officer/Principal | - | 18-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tommy Thompson
CHM | Chairman | 81 | 12-04-15 |
Cooper Collins
BRD | Director/Board Member | 45 | 12-02-27 |
Gail Naughton
BRD | Director/Board Member | 69 | 20-03-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 2.22 | +4.72% | 22,150 |
24-05-16 | 2.12 | +1.44% | 19,904 |
24-05-15 | 2.09 | +2.45% | 10,244 |
24-05-14 | 2.04 | -1.92% | 14,885 |
24-05-13 | 2.08 | +2.46% | 10,194 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-1.33% | 25.6M | |
+16.03% | 79.03B | |
+10.23% | 8.96B | |
-10.76% | 5.19B | |
+51.58% | 4.77B | |
+12.50% | 4.26B | |
-20.70% | 2.37B | |
+12.83% | 2.3B | |
-29.65% | 2.21B | |
+19.51% | 2.17B |
- Stock Market
- Equities
- TXMD Stock